JN-170
JN-170 is a potent and highly selective inhibitor and transport corrector of human SLC6A19 (IC50=47 nM). Furthermore, at a concentration of 35 μM, JN-170 exhibits no activity against SLC1A5, SLC7A5, or SLC6A8. JN-170 is applicable to research on phenylketonuria (PKU) and hyperphenylalaninemia. JN-170 is also suitable for studies related to various metabolic disorders, including tyrosinemia, maple syrup urine disease, urea cycle disorders, and hyperammonemia.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3032920-98-9
- Formel: C20H21F3N6O2
- Molecular Weight:434.41
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
SLC6A19[1]
In Vitro
JN-170 (compound 16) blocks SLC6A19, thereby reducing intestinal absorption and renal reabsorption of phenylalanine, and lowering phenylalanine levels in the blood. Moreover, the high selectivity of JN-170 greatly reduces the risk of side effects caused by off-target effects, such as avoiding interference with cell growth (SLC1A5 / SLC7A5) or impairment of brain function (SLC6A8)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 3032920-98-9
-
Molecular Weight 434.41
-
Formel C20H21F3N6O2
-
SMILES
O=C(NCCC1(CC1)N)N2C[C@](C3=NC(C4=CC=C(C=C4)C#N)=NO3)(CC2)C(F)(F)F
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)